Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Outlook Therapeutics Inc (NASDAQ: OTLK)

 
OTLK Technical Analysis
5
As on 13th Nov 2025 OTLK STOCK Price closed @ 1.47 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.40 & Strong Sell for SHORT-TERM with Stoploss of 7.62 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

OTLKSTOCK Price

Open 1.46 Change Price %
High 1.83 1 Day 0.19 14.84
Low 1.36 1 Week 0.26 21.49
Close 1.47 1 Month 0.40 37.38
Volume 48006815 1 Year -5.75 -79.64
52 Week High 9.22 | 52 Week Low 0.85
 
NASDAQ USA Most Active Stocks
NVVE 0.48 200.00%
LPTX 2.05 365.91%
AMRS 0.14 100.00%
WBA 11.98 0.50%
ONDS 6.56 19.06%
NVDA 186.86 -3.58%
OPEN 8.56 -8.64%
LMDX 0.02 0.00%
TSLA 401.99 -6.64%
PLUG 2.49 -8.79%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
LPTX 2.05 365.91%
MRSN 27.43 209.24%
NDRAW 0.03 200.00%
NVVE 0.48 200.00%
 
NASDAQ USA Top Losers Stocks
COMSP 0.00 -100.00%
FPAY 0.01 -94.74%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
ZIVOW 0.06 -85.00%
ORGS 0.15 -83.52%
OTRK 0.07 -78.79%
ACAQ-UN 2.50 -73.49%
AGBA 0.35 -71.31%
 
 
OTLK
Daily Charts		 OTLK
Intraday Charts		 Whats New @
Bazaartrend		 OTLK
Free Analysis
 
OTLK Important Levels Intraday
RESISTANCE2.38
RESISTANCE2.09
RESISTANCE1.91
RESISTANCE1.73
SUPPORT1.21
SUPPORT1.03
SUPPORT0.85
SUPPORT0.56
 
OTLK Forecast November 2025
Share
4th UP Forecast6.08
3rd UP Forecast4.6
2nd UP Forecast3.69
1st UP Forecast2.77
1st DOWN Forecast0.17
2nd DOWN Forecast-0.75
3rd DOWN Forecast-1.66
4th DOWN Forecast-3.14
 
OTLK Weekly Forecast
4th UP Forecast4.07
3rd UP Forecast3.24
2nd UP Forecast2.72
1st UP Forecast2.21
1st DOWN Forecast0.73
2nd DOWN Forecast0.22
3rd DOWN Forecast-0.30
4th DOWN Forecast-1.13
 
OTLK Forecast2025
4th UP Forecast17.77
3rd UP Forecast12.54
2nd UP Forecast9.31
1st UP Forecast6.08
1st DOWN Forecast-3.14
2nd DOWN Forecast-6.37
3rd DOWN Forecast-9.6
4th DOWN Forecast-14.83
 
 
OTLK Other Details
Segment EQ
Market Capital 366462656.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
OTLK Address
OTLK
 
OTLK Latest News
 
Your Comments and Response on Outlook Therapeutics Inc
 
OTLK Business Profile
Outlook Therapeutics, Inc., a late clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead product candidate is ONS-5010, a proprietary ophthalmic formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration and license agreements with IPCA Laboratories Limited; Laboratorios Liomont, S.A. de C.V.; BioLexis Pte. Ltd.; and Zhejiang Huahai Pharmaceutical Co., Ltd. The company was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc. in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey. Address: Building F, Iselin, NJ, United States, 08830
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service